Avoiding graft recooling after normothermic perfusion in liver transplantation
Official title: Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation: a Multicenter, Parallel-group, Open-label, Non-inferiority Randomized Controlled Trial
Run by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · NCT07692490 · Data updated 2026-11-12
This trial tests whether skipping the cooling step before placing a donor liver into a recipient helps outcomes for adults receiving livers preserved with normothermic or sequential perfusion.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 170 (estimated) |
| Sponsor | The Mediterranean Institute for Transplantation and Advanced Specialized Therapies Academic / other |
| Locations | 14 sites (Ancona and 13 other locations) |
| Status | Recruiting |
| Started | July 7, 2026 |
| Main results expected | October 6, 2028 |
| Study ends | October 6, 2028 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT07692490 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) listed for primary liver transplantation with grafts preserved by normothermic or SHNMP perfusion at participating centers.
✕Probably not a fit
Patients receiving grafts not affected by the recooling approach or whose injury risk is unrelated to perfusion temperature may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, open-label study compares two implantation approaches in adult liver transplant recipients: standard recooling with cold preservation solution versus immediate reperfusion without recooling using a room-temperature albumin flush. It is a randomized, parallel-group, non-inferiority design to see if avoiding recooling is not worse for early graft function. The primary endpoint is the occurrence of Early Allograft Dysfunction by Olthoff criteria. Participants are adults listed for primary liver transplantation with grafts preserved by normothermic machine perfusion or SHNMP, randomized 1:1 to the two strategies. The study analyzes early post-transplant outcomes and safety across multiple centers.
Why it matters
Potential benefit: If successful, avoiding recooling could reduce temperature-related injury and improve early graft function after liver transplantation.
How similar studies have gone: Prior data suggest temperature changes can influence ischemia-reperfusion injury, but this specific recooling strategy is novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * Listed for primary liver transplantation at the participating institution. * Assigned a liver graft preserved with normothermic machine perfusion or sequential hypothermic- normothermic machine perfusion (SHNMP). * Signed and dated informed consent prior study inclusion. Exclusion Criteria: * Pediatric patients (age \< 18 years) * Patients undergoing re-transplantation (history of previous liver transplantation) * Patients with acute liver failure * Patients undergoing multi-organ transplantation (e.g., liver-kidney, liver-heart) * Temporarily unconscious patients * Patients unable to freely express consent.
Where it's running
-
IRCCS ISMETT - Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione
Palermo, Italy Recruiting -
Università Politecnica delle Marche, AUO delle Marche
Ancona, Italy Not yet recruiting -
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari - Ospedale Giovanni XXIII
Bari, Italy Not yet recruiting -
ASST Papa Giovanni XXIII
Bergamo, Italy Not yet recruiting -
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy Not yet recruiting -
Ospedale Università Policlinico San Martino - IRCCS
Genova, Italy Not yet recruiting
Show 8 more locations
-
Università di Modena e Reggio Emilia
Modena, Italy Not yet recruiting -
Azienda Ospedale-Università di Padova
Padova, Italy Not yet recruiting -
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy Not yet recruiting -
Fondazione PTV - Policlinico Tor Vergata
Roma, Italy Not yet recruiting -
Azienda Ospedaliera San Camillo Forlanini
Roma, Italy Not yet recruiting -
Azienda Ospedaliero-Universitaria Policlinico Umberto I - Sapienza Università di Roma
Roma, Italy Not yet recruiting -
Fondazione Policlinico "Agostino Gemelli" IRCCS
Roma, Italy Not yet recruiting -
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy Not yet recruiting
Study contacts
- Study coordinator: Salvatore Gruttadauria
- Email: sgruttadauria@ismett.edu
- Phone: 0912192618
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immune biomarkers to predict complications after liver transplantation
This study tests immune biomarkers in adults after liver transplant to see if changes in markers relate to infections, rejection, or viral reactivation within the first year.
-
Restrictive fluid strategy with phlebotomy during liver transplantation
This study tests whether a restrictive fluid plan with phlebotomy during liver transplant helps patients recover better than a more fluid-intensive plan.
-
Monitoring blood markers during DIEP flap breast reconstruction
We will see if measuring inflammation and oxidative stress markers in blood before and during the first 72 hours after DIEP flap reconstruction helps map recovery patterns for women having immediate breast reconstruction after mastectomy.
-
BX-001N to prevent kidney injury after cardiac surgery with total circulatory arrest
This study will see if BX-001N can prevent acute kidney injury and later major kidney problems in adults undergoing cardiac surgery with total circulatory arrest.
-
Using remote ischemic conditioning to improve outcomes for patients undergoing off-pump coronary artery bypass grafting
This study is testing if a special treatment called remote ischemic conditioning can help patients with coronary artery disease recover better after heart surgery without using a heart-lung machine.
-
Infusion of sodium lactate after cardiac arrest
This study is testing if giving a special solution called sodium lactate to patients who have just been revived from cardiac arrest can help protect their brain and reduce damage.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.